# PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism

> **NCT05958784** · NA · COMPLETED · sponsor: **University of Guelph** · enrollment: 7 (actual)

## Conditions studied

- Autosomal Recessive Disorder (Genetic Carriers of PKU)

## Interventions

- **DIETARY_SUPPLEMENT:** L-Phenylalanine

## Key facts

- **NCT ID:** NCT05958784
- **Lead sponsor:** University of Guelph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05958784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05958784, "PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05958784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*